55 related articles for article (PubMed ID: 23388474)
21. Interaction between delta-9-tetrahydrocannabinol and indomethacin.
Green K; Kearse EC; McIntyre OL
Ophthalmic Res; 2001; 33(4):217-20. PubMed ID: 11464074
[TBL] [Abstract][Full Text] [Related]
22. Alteration in the level of endogenous hypothalamic prostaglandins induced by delta 9-tetrahydrocannabinol in the rat.
Coupar IM; Taylor DA
Br J Pharmacol; 1982 May; 76(1):115-9. PubMed ID: 6282371
[TBL] [Abstract][Full Text] [Related]
23. Cardiovascular effects of delta 9- and delta 9(11)-tetrahydrocannabinol and their interaction with epinephrine.
Estrada U; Brase DA; Martin BR; Dewey WL
Life Sci; 1987 Jul; 41(1):79-87. PubMed ID: 3037218
[TBL] [Abstract][Full Text] [Related]
24. Lack of cardiovascular effects of delta-9-tetrahydrocannabinol in chemically denervated men.
Kanakis C; Pouget M; Rosen KM
Ann Intern Med; 1979 Oct; 91(4):571-4. PubMed ID: 484957
[TBL] [Abstract][Full Text] [Related]
25. Evidence for a dual mechanism of gastric motor responses to intravenously administered endothelin-1 in anesthetized rats.
Krowicki ZK; Hornby PJ
J Physiol Paris; 1997; 91(3-5):203-7. PubMed ID: 9403795
[TBL] [Abstract][Full Text] [Related]
26. Cardiovascular effects of (-)-11-OH-delta 8-tetrahydrocannabinol-dimethylheptyl in rats.
Vidrio H; Sánchez-Salvatori MA; Medina M
J Cardiovasc Pharmacol; 1996 Aug; 28(2):332-6. PubMed ID: 8856492
[TBL] [Abstract][Full Text] [Related]
27. Effects of delta-9-tetrahydrocannabinol on the cardiovascular system, and pressor and behavioral responses to brain stimulation in rats.
Kawasaki H; Watanabe S; Oishi R; Ueki S
Jpn J Pharmacol; 1980 Aug; 30(4):493-502. PubMed ID: 6259394
[TBL] [Abstract][Full Text] [Related]
28. The effects of adrenalectomy on the cardiovascular responses to delta 1-tetrahydrocannabinol in rats.
Li DM; Chung JP
Clin Exp Pharmacol Physiol; 1978; 5(3):207-13. PubMed ID: 668209
[TBL] [Abstract][Full Text] [Related]
29. Site of analgesic action of a non-steroidal, anti-inflammatory drug, tolmetin sodium, in rats.
Nakamura H; Shimizu M
Br J Pharmacol; 1981 Jul; 73(3):779-85. PubMed ID: 7248666
[TBL] [Abstract][Full Text] [Related]
30. A Systematic Review and Meta-Analysis of the In Vivo Haemodynamic Effects of Δ⁸-Tetrahydrocannabinol.
Sultan SR; Millar SA; O'Sullivan SE; England TJ
Pharmaceuticals (Basel); 2018 Jan; 11(1):. PubMed ID: 29385080
[TBL] [Abstract][Full Text] [Related]
31. The effects of ?(9)-tetrahydrocannabinol ?(9)-THC) on the regional concentrations of spermidine in the rat brain.
Lewis SJ; Fennessy MR; Verberne AJ; Jarrott B; Taylor DA
Neurochem Int; 1986; 9(1):99-102. PubMed ID: 20493106
[TBL] [Abstract][Full Text] [Related]
32. A pilot study of orally administered Δ(1)-trans-tetrahydrocannabinol in the management of patients undergoing radiotherapy for carcinoma of the bronchus.
Davies BH; Weatherstone RM; Graham JD; Griffiths RD
Br J Clin Pharmacol; 1974 Aug; 1(4):301-6. PubMed ID: 22454883
[TBL] [Abstract][Full Text] [Related]
33. Acute toxicity of delta-9-tetrahydrocannabinol in rats and mice.
Phillips RN; Turk RF; Forney RB
Proc Soc Exp Biol Med; 1971 Jan; 136(1):260-3. PubMed ID: 5540621
[No Abstract] [Full Text] [Related]
34. Expression of Concern: Neuroanatomical correlates of the inhibition of tremulous jaw movements in rats by a combination of memantine and Δ
Br J Pharmacol; 2023 Aug; 180(15):2035. PubMed ID: 37271499
[No Abstract] [Full Text] [Related]
35. Correction to: Effect of Lipid Vehicles on Solubility, Stability, and Topical Permeation of Delta-9-Tetrahydrocannabinol.
Shankar VK; Shettar A; Rangappa S; Ellis I; Dave M; Murthy R; Murthy SN
AAPS PharmSciTech; 2022 Aug; 23(7):240. PubMed ID: 36002709
[No Abstract] [Full Text] [Related]
36. Cannabinoids for Treating Cardiovascular Disorders: Putting Together a Complex Puzzle.
Eid BG
J Microsc Ultrastruct; 2018; 6(4):171-176. PubMed ID: 30464888
[TBL] [Abstract][Full Text] [Related]
37. Prevention of Diet-Induced Obesity Effects on Body Weight and Gut Microbiota in Mice Treated Chronically with Δ9-Tetrahydrocannabinol.
Cluny NL; Keenan CM; Reimer RA; Le Foll B; Sharkey KA
PLoS One; 2015; 10(12):e0144270. PubMed ID: 26633823
[TBL] [Abstract][Full Text] [Related]
38. In vitro and non-invasive in vivo effects of the cannabinoid-1 receptor agonist AM841 on gastrointestinal motor function in the rat.
Abalo R; Chen C; Vera G; Fichna J; Thakur GA; López-Pérez AE; Makriyannis A; Martín-Fontelles MI; Storr M
Neurogastroenterol Motil; 2015 Dec; 27(12):1721-35. PubMed ID: 26387676
[TBL] [Abstract][Full Text] [Related]
39. Involvement of hindbrain and peripheral prostanoids in gastric motor and cardiovascular responses to delta-9-tetrahydrocannabinol in the rat.
Krowicki ZK
J Physiol Pharmacol; 2012 Dec; 63(6):581-8. PubMed ID: 23388474
[TBL] [Abstract][Full Text] [Related]
40. Behavioural sensitization after repeated exposure to Delta 9-tetrahydrocannabinol and cross-sensitization with morphine.
Cadoni C; Pisanu A; Solinas M; Acquas E; Di Chiara G
Psychopharmacology (Berl); 2001 Nov; 158(3):259-66. PubMed ID: 11713615
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
